In an unusual move, the chair of a Food and Drug Administration panel is defying a recommendation that his own panel made last week to endorse a powerful opioid painkiller, because he believes the drug represents a “danger” to public...
Important Senate Finance hearing on behavioral health this am. Great experts, including Reggie Williams @RW_Intl. B… https://t.co/wI1h5s0BXZ —
2 years 1 month ago
RT @ABIMFoundation: Happy #DoctorsDay! Thank you to all physicians for your dedication to the profession and for helping people and society… —
2 years 1 month ago